HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mucinous breast carcinoma and mixed mucinous-infiltrating ductal carcinoma: a comparative cytologic study.

Abstract
In its pure form, mucinous breast carcinoma (MC) has a much better prognosis than infiltrating ductal carcinoma (IDC). Mixed MC-IDC has the prognosis of IDC. We compared the fine-needle aspiration (FNA) cytology and histology of nine cases of pure MC with 13 cases of mixed MC-IDC. While typical of pure MC, abundant mucin (3+/3+) was noted in smears from three cases of mixed tumor and is thus necessary but not sufficient for a diagnosis of pure MC. Cellular pleomorphism has been said not to be a feature of MC; however, we found occasional large cells markedly different from the typical small uniform cells of MC in four pure and seven mixed tumors. Cytologic features indicative of a mixed tumor include one or more smears totally without mucin, scantly amounts of mucin, or necrosis. A combination of features indicative of pure mucinous carcinoma in FNA included abundant mucin on all smears, no pleomorphism, and no necrosis. Many cases will have smear patterns that are not typical of either profile and should probably be designated as carcinoma with a mucinous component.
AuthorsM W Stanley, E M Tani, L Skoog
JournalDiagnostic cytopathology (Diagn Cytopathol) Vol. 5 Issue 2 Pg. 134-8 ( 1989) ISSN: 8755-1039 [Print] United States
PMID2550188 (Publication Type: Comparative Study, Journal Article)
Topics
  • Adenocarcinoma, Mucinous (pathology)
  • Aged
  • Aged, 80 and over
  • Biopsy, Needle
  • Breast Neoplasms (pathology)
  • Carcinoma, Intraductal, Noninfiltrating (pathology)
  • Female
  • Humans
  • Middle Aged
  • Neoplasms, Multiple Primary (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: